Treatment of pityriasis rubra pilaris with risankizumab in two cases
نویسندگان
چکیده
JDDG: Journal der Deutschen Dermatologischen GesellschaftVolume 19, Issue 8 p. 1207-1209 Clinical LetterOpen Access Treatment of pityriasis rubra pilaris with risankizumab in two cases Christian Kromer, Kromer Department Dermatology, Venereology, and Allergology, University Medical Center, Göttingen, GermanySearch for more papers by this authorMichael P. Schön, Michael Schön Germany Lower Saxony Institute Occupational authorRotraut Mössner, Corresponding Author Rotraut Mössner [email protected] Correspondence to MD Dermatology Center Göttingen Robert-Koch-Strasse 40 37075 E-mail: [email protected] author First published: 10 May 2021 https://doi.org/10.1111/ddg.14504AboutPDF ToolsRequest permissionExport citationAdd favoritesTrack citation ShareShare Give accessShare full text full-text accessPlease review our Terms Conditions Use check box below share version article.I have read accept the Wiley Online Library UseShareable LinkUse link a article your friends colleagues. Learn more.Copy URL Share linkShare onFacebookTwitterLinked InRedditWechat No abstract is available article. Volume19, Issue8August 2021Pages RelatedInformation
منابع مشابه
Living with pityriasis rubra pilaris.
Dermatology nurses and other health care professionals may sometimes fail to appreciate and recognize the physical and emotional challenges faced by patients with a particular chronic dermatologic disease or condition. To better bring patients’ feelings and perceptions into focus, the Dermatology Nursing Editorial Board is excited to introduce a new series, “Patients’ Perspectives: Living With....
متن کاملPhotosensitive pityriasis rubra pilaris
Pityriasis rubra pilaris (PRP) is a rare, chronic papulosquamous skin disorder. The skin lesions rarely have a predilection to sun-exposed areas although it is known that natural sunlight and phototherapy can exacerbate PRP [1–4]. We present a case of a patient suffering from pityriasis rubra pilaris with photoexposed distribution and photosensitivity exclusively to UVB objectively detected by ...
متن کاملAdult onset pityriasis rubra pilaris.
Pityriasis rubra pilaris (PRP) has always been an intriguing topic ever since its inception. It is a group of chronic disorders characterized by reddish orange plaques with pityriasiform scaling showing follicular keratoses, palmoplantar keratoderma, and sometimes, erythroderma. It occurs all over the world but with racial variations. Its incidence might vary and the age at onset, behavior, cli...
متن کاملSuccessful treatment of type II pityriasis rubra pilaris with secukinumab
IL: interleukin PRP: pityriasis rubra pilaris TNF: tumor necrosis factor INTRODUCTION Pityriasis rubra pilaris (PRP) is a heterogeneous inflammatory skin disease characterized by follicular papules, orange palmoplantar keratoderma, and erythematous scaly patches with islands of skin sparing. Type II PRP is a rare, severe, chronic form of PRP presenting atypical features including long disease d...
متن کاملPityriasis rubra pilaris successfully treated with infliximab.
Sir, Pityriasis rubra pilaris (PRP) is an uncommon, idiopathic, papulosquamous disorder that often progresses to erythroderma and causes disabling keratoderma. The disease is classified into 5 groups on the basis of clinical appearance, behaviour and prognosis, as proposed by Griffiths in 1980 (1). Recently, a sixth group has been proposed in order to acknowledge the HIV-associated type of PRP ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal der Deutschen Dermatologischen Gesellschaft
سال: 2021
ISSN: ['1610-0379', '1610-0387']
DOI: https://doi.org/10.1111/ddg.14504